The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Purixan 20 mg/ml oral suspension in 100 ml bottles. The contract, valued at $1,022.86, has an ultimate completion date of December 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group, valued at $499,999,999 and valid through November 2026, which allows the DLA to issue orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation, enabling DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure this direct federal award.
Generated 3/2/25, 12:46 AM